Literature DB >> 28853076

Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule.

M Yu Shkurnikov1,2, Yu A Makarova3, E N Knyazev3,4, K A Fomicheva4, A V Galatenko3, K M Nyushko4, V V Galatenko3, V I Vechorko5, B Ya Alekseev4.   

Abstract

Profiles of circulating microRNA in the plasma of patients with prostate cancer with pathomorphological stages pT2, pT3, and pT4 are analyzed. The level of circulating microRNA hsa-miR-619-5p is elevated in patients with extracapsular spreading of the tumor, increasing significantly from stage pT2 to stage pT4.

Entities:  

Keywords:  blood plasma; cancer stage; little invasive diagnosis; microRNA; prostatic cancer

Mesh:

Substances:

Year:  2017        PMID: 28853076     DOI: 10.1007/s10517-017-3831-x

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

Review 1.  The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Authors:  Monyse de Nóbrega; Mariana Bisarro Dos Reis; Érica Romão Pereira; Marilesia Ferreira de Souza; Ilce Mara de Syllos Cólus
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-04       Impact factor: 4.322

2.  Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.

Authors:  Precious Takondwa Makondi; Po-Li Wei; Chien-Yu Huang; Yu-Jia Chang
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

3.  MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer.

Authors:  Song Gao; Zhiying Zhao; Rong Wu; Lina Wu; Xin Tian; Zhenyong Zhang
Journal:  Onco Targets Ther       Date:  2018-08-14       Impact factor: 4.147

4.  Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism.

Authors:  Huda Alfardus; Maria de Los Angeles Estevez-Cebrero; Jonathan Rowlinson; Amna Aboalmaaly; Anbarasu Lourdusamy; Salah Abdelrazig; Catherine Ortori; Richard Grundy; Dong-Hyun Kim; Alan McIntyre; Stuart Smith
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.